...
首页> 外文期刊>Архив патологии >Prognostic value of the expression of thyreoglobulin and oncomarkers (p53, EGFR, ret-oncogene) in different types of papillary carcinoma of the thyroid: clinicomorphological and immunohistochemical studies
【24h】

Prognostic value of the expression of thyreoglobulin and oncomarkers (p53, EGFR, ret-oncogene) in different types of papillary carcinoma of the thyroid: clinicomorphological and immunohistochemical studies

机译:甲状腺球蛋白和促癌蛋白(p53,EGFR,ret-oncogene)的表达对不同类型甲状腺乳头状癌的预后价值:临床形态学和免疫组化研究

获取原文
获取原文并翻译 | 示例
           

摘要

The surgical material obtained from 57 patients was immunohistochemically studied. Immunohistochemistry with quantitative and semiquantitative analyses of the results of test was used to define the expression of oncomarkers p53, EGRF, ret-oncogene, and thyreoglobulin. The expression of thyreoglobulin, EGRF, and ret-oncogene reflects the malignant potential of papillary carcinoma of the thyroid and and may be recommended as a predictive marker. The low expression of thyreoglobulin and the high expression of p53 and ret-oncogene are markers of a poor prognosis and tumor recurrence. EGFR expression is not of predictive value. MB3 proposed by the authors may be recommended for the determination of the malignant potential of papillary carcinoma of the thyroid.
机译:对57例患者的手术材料进行了免疫组织化学研究。免疫组织化学结合测试结果的定量和半定量分析,用于定义oncomarkers p53,EGRF,视网膜癌基因和甲状腺球蛋白的表达。甲状腺球蛋白,EGRF和视网膜癌基因的表达反映了甲状腺乳头状癌的恶性潜能,因此可能被推荐作为预测性标志物。甲状腺球蛋白的低表达以及p53和ret-oncogene的高表达是不良预后和肿瘤复发的标志。 EGFR的表达没有预测价值。作者建议使用MB3来确定甲状腺乳头状癌的恶性程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号